Hematology
Volume 27, 2022 - Issue 1
Open access
1,577
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation
Haruka Teshigawara-Tanabea Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan;b Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japanhttps://orcid.org/0000-0002-3887-9001
, Maki Hagiharab Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-4928-2147
, https://orcid.org/0000-0002-4928-2147
Jun Aokic Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
, Satoshi Koyamab Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
, Hiroyuki Takahashib Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japanhttps://orcid.org/0000-0001-5188-9063
, Yuki Nakajimab Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
, Hiroyoshi Kunimotoa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan;b Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
, Takayoshi Tachibanad Department of Hematology, Kanagawa Cancer Center, Yokohama, Japanhttps://orcid.org/0000-0002-7780-4459
, Takuya Miyazakib Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
, Kenji Matsumotob Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
, Masatsugu Tanakad Department of Hematology, Kanagawa Cancer Center, Yokohama, Japanhttps://orcid.org/0000-0001-8814-230X
, Etsuko Yamazakie Department of Laboratory Medicine, Yokohama City University Hospital, Yokohama, Japan
, Shin Fujisawac Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
, Heiwa Kanamorid Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
, Masataka Tagurif Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japanhttps://orcid.org/0000-0001-8902-0056
& Hideaki Nakajimaa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan;b Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, JapanCorrespondence[email protected]
[email protected]
https://orcid.org/0000-0002-8967-4954
show all[email protected]
https://orcid.org/0000-0002-8967-4954
Pages 620-628
|
Published online: 27 May 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.